ICV administration of selective delta and kappa opioid receptor agonists produce antinociception with limited side effects in the rat
Leung, C.G.; Weinger, M.B.; Wieslander, C.; Wood, D.; Davidson, L.; Brisbane, C.; Tanguilig, C.; Ghausi, S.; Schulteis, G.
Society for Neuroscience Abstracts 24(1-2): 890
1998
ISSN/ISBN: 0190-5295 Accession: 031766509
PDF emailed within 1 workday: $29.90
Related References
Armstrong, R.A.; Sewell, R.D.E.; Spencer, P.S.J. 1990: D 1 and d 2 dopamine agonists produce contrasting effects on mu kappa and delta opioid mediated antinociception Journal of Pharmacy and Pharmacology 42(Suppl): 184PBaamonde, A.; Lastra, A.; Juárez, Lía.; García, Vónica.; Hidalgo, Aín.; Menéndez, L. 2005: Effects of the local administration of selective mu-, delta-and kappa-opioid receptor agonists on osteosarcoma-induced hyperalgesia Naunyn-Schmiedeberg's Archives of Pharmacology 372(3): 213-219
Tseng, L.F.; Collins, K.A.; Kampine, J.P. 1994: Antisense oligodeoxynucleotide to a delta-opioid receptor selectively blocks the spinal antinociception induced by delta-, but not mu- or kappa-opioid receptor agonists in the mouse European Journal of Pharmacology 258(1-2): R1-R3
Roerig, S.C.; Fujimoto, J.M. 1989: Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice Journal of Pharmacology and Experimental Therapeutics 249(3): 762-768
Wang, H.Q.; Kampine, J.P.; Tseng, L.F. 1996: Antisense oligodeoxynucleotide to a delta-opioid receptor messenger RNA selectively blocks the antinociception induced by intracerebroventricularly administered delta-, but not mu-, epsilon- or kappa-opioid receptor agonists in the mouse Neuroscience 75(2): 445-452
Leighton, G.E.; Rodriguez, R.E.; Hill, R.G.; Hughes, J. 1988: Kappa-Opioid agonists produce antinociception after I.v. and I.c.v. but not intrathecal administration in the rat British Journal of Pharmacology 93(3): 553-560
Walsh, J.P.; Clarke, I.J. 1996: Effects of central administration of highly selective opioid mu-, delta- and kappa-receptor agonists on plasma luteinizing hormone (LH), prolactin, and the estrogen-induced LH surge in ovariectomized ewes Endocrinology 137(9): 3640-3648
Walsh, J.P.; Clarke, I.J. 1996: Effects of central administration of highly selective opioid micro -, delta - and kappa -receptor agonists on plasma luteinizing hormone (LH), prolactin, and the estrogen-induced LH surge in ovariectomized ewes Endocrinology Philadelphia 137(9): 3640-3648
Schiller, P.W.; Weltrowska, G.; Nguyen, T.M.-D.; Lemieux, C.; Chung, N.N.; Lu, Y. 2003: Conversion of delta-, kappa- and mu-receptor selective opioid peptide agonists into delta-, kappa- and mu-selective antagonists Life Sciences 73(6): 691-698
Hosohata, Y.; Vanderah, T.W.; Burkey, T.H.; Ossipov, M.H.; Kovelowski, C.J.; Sora, I.; Uhl, G.R.; Zhang, X.; Rice, K.C.; Roeske, W.R.; Hruby, V.J.; Yamamura, H.I.; Lai, J.; Porreca, F. 2000: Delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice European Journal of Pharmacology 388(3): 241-248
Romero, T.R.L.; Guzzo, L.S.; Duarte, I.D.G. 2012: Mu, delta, and kappa opioid receptor agonists induce peripheral antinociception by activation of endogenous noradrenergic system Journal of Neuroscience Research 90(8): 1654-1661
da Fonseca Pacheco, D.; Klein, A.; de Castro Perez, A.; da Fonseca Pacheco, C.M.; de Francischi, J.N.; Duarte, I.D.G. 2008: The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors British Journal of Pharmacology 154(5): 1143-1149
Cao, Y.J.; Bhargava, H.N. 1997: Effect of cocaine on thermal nociception, morphine antinociception and on tolerance to mu-, delta- and kappa-opioid receptor agonists in mice FASEB Journal 11(3): A203
Pfaus, J.G.; Pfaff, D.W. 1991: Selective mu opioid receptor agonists inhibit whereas delta and kappa receptor agonists facilitate lordosis behavior in the female rat differential modulation by progesterone Society for Neuroscience Abstracts 17(1-2): 498
Lester, P.A.; Traynor, J.R. 2006: Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes Brain Research 1073-1074: 290-296
Delander, G.E.; Keil, G.J.II 1992: Selective adenosine and delta opioid receptor agonists it interact synergistically to induced antinociception FASEB Journal 6(4): A1300
Ito, S.; Mori, T.; Sawaguchi, T. 2006: Differential effects of micro-opioid, delta-opioid and kappa-opioid receptor agonists on dopamine receptor agonist-induced climbing behavior in mice Behavioural Pharmacology 17(8): 691-701
Li, F.; Yue, F.; Zhang, W.; Xu, B.; Wang, Y.; Zhang, X. 2023: A Novel Multi-Target Mu/Delta Opioid Receptor Agonist, HAGD, Produced Potent Peripheral Antinociception with Limited Side Effects in Mice and Minimal Impact on Human Sperm Motility in Vitro Molecules 28(1)
Bilsky, E.J.; Wang, T.; Lai, J.; Porreca, F. 1996: Selective blockade of peripheral delta opioid agonist induced antinociception by intrathecal administration of delta receptor antisense oligodeoxynucleotide Neuroscience Letters 220(3): 155-158
Morgan, E.L. 1996: Regulation of human B lymphocyte activation by opioid peptide hormones. Inhibition of IgG production by opioid receptor class (mu-, kappa-, and delta-) selective agonists Journal of Neuroimmunology 65(1): 21-30